275 related articles for article (PubMed ID: 28492437)
1. Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve Ligation-Induced Pain in Rats.
Shiue SJ; Peng HY; Lin CR; Wang SW; Rau RH; Cheng JK
Reg Anesth Pain Med; 2017; 42(4):499-506. PubMed ID: 28492437
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model.
Cui JH; Kim WM; Lee HG; Kim YO; Kim CM; Yoon MH
Neurosci Lett; 2011 Apr; 493(3):67-71. PubMed ID: 21195743
[TBL] [Abstract][Full Text] [Related]
3. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
4. Chronic intrathecal infusion of mibefradil, ethosuximide and nickel attenuates nerve ligation-induced pain in rats.
Chen YL; Tsaur ML; Wang SW; Wang TY; Hung YC; Lin CS; Chang YF; Wang YC; Shiue SJ; Cheng JK
Br J Anaesth; 2015 Jul; 115(1):105-11. PubMed ID: 26089446
[TBL] [Abstract][Full Text] [Related]
5. Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement.
Spyridakos D; Papadogkonaki S; Dionysopoulou S; Mastrodimou N; Polioudaki H; Thermos K
Neurochem Int; 2021 Jan; 142():104907. PubMed ID: 33220388
[TBL] [Abstract][Full Text] [Related]
6. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
Johanek LM; Simone DA
Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
[TBL] [Abstract][Full Text] [Related]
9. Histone methyltransferase G9a diminishes expression of cannabinoid CB
Luo Y; Zhang J; Chen L; Chen SR; Chen H; Zhang G; Pan HL
J Biol Chem; 2020 Mar; 295(11):3553-3562. PubMed ID: 32024693
[TBL] [Abstract][Full Text] [Related]
10. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.
Hama A; Sagen J
Brain Res; 2011 Sep; 1412():44-54. PubMed ID: 21813113
[TBL] [Abstract][Full Text] [Related]
11. Chronic intrathecal infusion of minocycline prevents the development of spinal-nerve ligation-induced pain in rats.
Lin CS; Tsaur ML; Chen CC; Wang TY; Lin CF; Lai YL; Hsu TC; Pan YY; Yang CH; Cheng JK
Reg Anesth Pain Med; 2007; 32(3):209-16. PubMed ID: 17543815
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273
[TBL] [Abstract][Full Text] [Related]
13. Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats.
Zhang M; Wang K; Ma M; Tian S; Wei N; Wang G
Anesth Analg; 2016 Apr; 122(4):1031-7. PubMed ID: 26720619
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat.
Hohmann AG; Tsou K; Walker JM
J Neurophysiol; 1999 Feb; 81(2):575-83. PubMed ID: 10036261
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal lamotrigine attenuates mechanical allodynia and suppresses microglial and astrocytic activation in a rat model of spinal nerve ligation.
Choi YS; Jun IG; Kim SH; Park JY
Yonsei Med J; 2013 Mar; 54(2):321-9. PubMed ID: 23364963
[TBL] [Abstract][Full Text] [Related]
16. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
[TBL] [Abstract][Full Text] [Related]
17. Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons.
Wotherspoon G; Fox A; McIntyre P; Colley S; Bevan S; Winter J
Neuroscience; 2005; 135(1):235-45. PubMed ID: 16084654
[TBL] [Abstract][Full Text] [Related]
18. Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.
Brownjohn PW; Ashton JC
Neuroscience; 2012 Feb; 203():180-93. PubMed ID: 22210507
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C
Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260
[TBL] [Abstract][Full Text] [Related]
20. Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice.
Ikeda H; Ikegami M; Kai M; Ohsawa M; Kamei J
Neuroscience; 2013 Oct; 250():446-54. PubMed ID: 23892011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
